Directory Интермедианты Gistaminergicakie funds Gistaminolitiki H_1-antigistaminne funds Erespal
This page is translated automatically with a help of Google Translate

Erespal

See also Fenspiride

Roman name

Eurespal

The composition and the form of

1 tablet coated liner contains fenspirida hydrochloride 80 mg. Supporting substances : calcium phosphate dwuzameshchenny, polymer, povidon, kolloidnyi anhydrous silicon, magnesium stearate, titanium dioxide, glicerol, macrogol 6000; Blistere in 15 pcs. , In box 2 ml blister.1 syrup-2 mg fenspirida hydrochloride. Supporting substances : honey aroma (honey, rum, alkogholata and alcohol extracts of honey, flowers roses and orange) extract root root (Figures customization root root, glucose syrup, Aniseed oil), and extract vanilinovy (buds furunculosis vanilla pods, glycerin, stain sunset yellow S metilparagidroksibenzoat, propilparagidroksibenzoat, Saccharine, sucrose, potassium sorbate, distilled water); in vial 150 ml, in the box one bottle.

Of drugs

Fenspirid has антибронхоконстрикто рным and �ротивовоспалительны�� properties due to the mechanism of :-an antagonist H_1-gistaminovh receptors has sossoudorasshiratm like papaverino, spasmolytic activity; - �ротивовоспалительны�� effects due to the decline of various factors inflammation (Cytokines, necrosis factor alpha tumors, metabolites arahidonova acid and free radicals), some of which also have bronhosujiwatm action. But these effects are observed only at very high doses.

Pharmacokinetics

Absorbed in the intestine relatively slow. C_max after taking into is in the range from 0.5 to 8 hrs (pills), or 6900 (syrup). T_1/2-12 p.m. Report mostly in the urine.

Indications

Rinofaringita, laringita; - Otita, sinusita; - Rinotraheobronhita; - Bronchitis; - Bronchial asthma (maintenance therapy); - Respiratory events, measles, pertussis and influenza (syrup).

Pregnancy and lactation

Not recommended during pregnancy, but pregnancy during treatment is not a ground for termination. Nursing mothers should be at the reception Erespala abandon breastfeeding.

Contraindications

Гиперчувствительност ь for the active substance and / or any of the components of the preparation. Pills are not recommended for use in children because A medication in the form of syrup.

Side-Effects

Diarrhoeal disorders (nausea, stomach), drowsiness, urticaria (syrup).

Specific guidance

The product is stain sanset yellow S, which received Erespala can provoke the allergic reactions, including asthmatic attacks, especially among those with a heightened sensitivity to aspirin.

Patient interaction

Prescribed drug interaction Erespal not described.

Storage conditions

List B. The temperature is not above 30 ° C

Shelf life

3 years

The registration

012547/02-2000

All products of this group